Form 4: Surrozen Executive Yang Li Reports Stock Option and RSU Grant

Yang Li, Executive Vice President of Research at Surrozen, Inc., reports the acquisition of stock options and restricted stock units (RSUs) in a recent SEC Form 4 filing.

Summary

• Yang Li, the Executive Vice President of Research at Surrozen, Inc., filed a Form 4 with the SEC.
• The filing reports the acquisition of 26,250 stock options with an exercise price of $10.48 on May 1, 2025.
• These options vest in 48 equal monthly installments from June 1, 2025, and expire on May 1, 2035.
• Li also acquired 8,750 restricted stock units (RSUs) on May 1, 2025.
• These RSUs vest over a two-year period, with 50% vesting on each of the first and second annual anniversary of the grant date.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of equity compensation is a standard practice and generally viewed favorably as it aligns executive interests with shareholder value. There are no negative indicators in the filing.

Positives

• The grant of stock options and RSUs to a key executive like Yang Li aligns their interests with those of the shareholders.
• The vesting schedules encourage long-term commitment from the executive.

Future Outlook

This filing does not contain any forward-looking statements about the company's future performance.

Industry Context

Stock option and RSU grants are common forms of executive compensation in the biotechnology industry, used to attract and retain talent and align their interests with company performance.

Comparison to Industry Standards

• Executive compensation packages, including stock options and RSUs, are standard practice in the biotech industry.
• Companies like Amgen, Gilead, and Biogen also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules (4-year for options, 2-year for RSUs) are typical for such grants.

Stakeholder Impact

• Shareholders may view the equity grants positively as they incentivize management to increase shareholder value.
• Employees may see this as a positive sign of the company investing in its leadership.

Key Dates

Keywords

Form 4, Surrozen, Stock Options, RSU, Yang Li, Executive Compensation, Beneficial Ownership